Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals

Blood. 2013 Sep 26;122(13):2282-3. doi: 10.1182/blood-2013-06-507012.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Cyclohexanes / therapeutic use*
  • Female
  • Graft vs Host Disease / immunology*
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Humans
  • Male
  • Triazoles / therapeutic use*
  • Viral Load / drug effects*

Substances

  • Cyclohexanes
  • Triazoles